Navigation Links
VG Life Sciences, Inc. Announces the Initiation of IND-Enabling Animal Safety Studies
Date:11/4/2013

SANTA BARBARA, Calif., Nov. 4, 2013 /PRNewswire/ -- VG Life Sciences, Inc. is a publicly traded (VGLS) biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

(Logo: http://photos.prnewswire.com/prnh/20131031/LA07859LOGO)

VG Life Sciences, Inc. has contracted ITR Laboratories Canada, Inc. to perform FDA IND enabling animal safety studies with its patented peptide VG1177. The studies will address the optimum route of administration and will provide key toxicological, pharmacological, genotoxicological, and toxicokinetic data for IND applications that VG Life Sciences, Inc. will submit for FDA review.

The inventor of VG1177 is Dr. Karen Newell Rogers, PhD at Texas A&M University School of Medicine and Chief Scientist at VG Life Sciences. "These animal safety studies mark an important step in advancing VG1177 from technology to treatment, and will provide key safety data in support of our coming clinical trials," said Dr. Newell Rogers.

Results from the studies are expected to conclude by July 2014.

"At our restructuring in July we identified three important initiatives that we needed to complete this year: raise additional capital, begin audited financials and start animal safety studies. We are proud we completed all these goals in less than 4 months. This sets the stage for key milestones in 2014," said John Tynan, VG Life Sciences' President and CEO. "Thus we are pleased to announce the start of this important pre-clinical study bringing us closer to monetize our intellectual property as outlined in our July 2013 Letter to Shareholders."

The VG1177 peptide prevents the survival of pro-inflammatory cells under conditions where inflammation is unwanted, thereby allowing the b
'/>"/>

SOURCE VG Life Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
3. KannaLife Sciences, Inc. Signs Exclusive License Agreement with National Institutes of Health Office of Technology Transfer (NIH-OTT)
4. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
5. Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY
6. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
7. Pressure BioSciences, Inc. to Discuss Second Quarter 2012 Financial Results and Provide Business Update
8. Pressure BioSciences, Inc. Reports 70% Revenue Growth for Second Consecutive Quarter
9. QPS Acquires JSW Life Sciences, Largest Independent Contract Research Organization in Austria
10. Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY
11. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015 About Neuroendovascular Coil ... to treat an unruptured and ruptured brain aneurysm ... treatment is either known as an endovascular coiling ... coil blocks the blood flow in an aneurysm. ... general anaesthesia by an interventional neuroradiologist using fluoroscopic ...
(Date:9/2/2015)... 2, 2015   About ELISA test ... technologies that is used for measuring the concentration of ... test uses various types of enzymes such as carbonic ... is detected by photometry or fluorometry. ELISA is used ... infectious diseases such as HIV, pernicious anemia, rotavirus, Rocky ...
(Date:9/2/2015)... 2, 2015   Physicians Rx Pharmacy ("PRxP") ... joined the organization as President and Chief Executive Officer.  ... President and Chief Executive Officer for Soleo Health Specialty ... of Physicians Rx Pharmacy, be responsible for leading the ... extremely pleased to bring Gaston on as the President ...
Breaking Medicine Technology:Global Neuroendovascular Coil Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2
... participate in controversial debate over effects of ... Simvastatin vs. Ezetimibe/Simvastatin, ... medical professionals, will air on XM Satellite Radio Channel,157 ... a candid medical,discussion on the much talked-about ENHANCE (Effect ...
... the Addition of L-MTP-PE to, Chemotherapy ... Osteosarcoma Patients, IRVINE, Calif., Feb. 4 ... the Journal of Clinical Oncology (JCO) has,published findings ... entitled "Osteosarcoma: The Addition of Muramyl Tripeptide to,Chemotherapy ...
Cached Medicine Technology:ReachMD Broadcasts First-of-its-Kind Physician Peer-Peer Discussion on ENHANCE Trial 2IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 2IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 3IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 4IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 5IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 6IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 7
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, ... announced the two leaders who will deliver keynote presentations at the upcoming Digital ... Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based in Beverly Hills, Luxury ... truly superb luxury vehicles based on which of the latest and greatest vehicles their ... step forward in pursuit of this goal: a 2015 Rolls Royce Wraith rental ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Western ... and Mildred Goldstein Charitable Trust to establish the Abraham and Mildred Goldstein Endowment ... months after WCHN recruited nationally known gynecologic oncologist Thomas J. Rutherford, MD, PhD ...
(Date:9/2/2015)... ... 2015 , ... Date and time: Oct. 3, 2015, 9 a.m. to 4 ... Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The ... best-selling author Sam Keen based on his new book which he co-authored with his ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... safety and efficacy endpoint data collection, cloud analytics and workflow solutions today ... The series enables pharmaceutical researchers to participate in interactive programs in which ...
Breaking Medicine News(10 mins):Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3
... Dec. 2 TROY Group, Inc.,(Pink Sheets: TROY), ... the first digital printer for printing the federally,mandated ... TROY SecureRx,printer allows healthcare providers to significantly reduce ... security regulations,established by the Center for Medicare and ...
... SAN JOSE, Calif., Dec. 2 eOn Communications,Corporation(TM) (Nasdaq: ... announced today that it has received a contract from ... at the Landstuhl Regional Medical,Center in Germany. Implementation ... April of 2009. , ...
... Shower(TM) brand just got,better with the addition of its new ... flavor contains Lifeguard(TM) Protection, a fortification,package with powerful antioxidant vitamins ... leading brands. , "We ... Sun Shower(TM) Super,Blends iced coffees, teas and lattes," said Chris ...
... SACRAMENTO, Calif., Dec. 2 MRME the publisher of ... the American,College of Cardiology (CA ACC), the largest ACC ... and impactful educational programs for,cardiologists. The CA ACC is ... of medical education activities. , ...
... and improves attention to the scan, study shows , , TUESDAY, ... the patient next to their radiological scans helps humanize each ... by radiologists, a new study finds. , As technological ... patient, putting a patient,s photo in his or her file ...
... MANCHESTER, N.H., Dec. 2 Anthem Blue Cross and ... have pledged more than,$175,000 to support over 220 not-for-profit ... Giving Campaign. The Anthem Blue Cross and Blue,Shield Foundation ... the total to more than $260,000 , ...
Cached Medicine News:Health News:TROY SecureRx Revolutionizes Prescription Printing 2Health News:TROY SecureRx Revolutionizes Prescription Printing 3Health News:TROY SecureRx Revolutionizes Prescription Printing 4Health News:eOn Communications Announces GSA Contract 2Health News:eOn Communications Announces GSA Contract 3Health News:New Sun Shower(TM) Super Blends: Iced Coffees, Teas, Lattes With Half the Calories 2Health News:Patients' Photos Help Boost Radiologists' Accuracy 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Associates Pledge More Than $260,000 to Community Organizations 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Associates Pledge More Than $260,000 to Community Organizations 3
Trial lens set +/- Cyl....
...
... of engineering and innovative design, the Burton ... and masterful workmanship. At Burton, we set ... industry a truly innovative concept, but to ... to quality construction and stringent testing, we ...
... Durable cast iron and steel construction for ... quiet and reliable up/down chair movement. Soft, ... of lasting comfort. Electro-magnetic counter-balanced slit lamp ... Low, only 24" high slit lamp arm ...
Medicine Products: